Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Metformin (1000mg) + Voglibose (0.3mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology, ENDOCRINOLOGY and Hormonal range
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Metformin 1000mg + Voglibose 0.3mg tablet is a dual-action anti-diabetic formulation used for the effective management of type 2 diabetes mellitus and postprandial hyperglycemia.
Metformin works by reducing hepatic glucose production and improving insulin sensitivity, while Voglibose slows carbohydrate absorption from the gut, effectively controlling blood sugar spikes after meals.
This tablet is commonly prescribed for patients with type 2 diabetes who require improved glycemic control, especially postprandial glucose management, ensuring stable blood sugar levels and reduced complications.
With proven efficacy, convenient oral dosing, and strong acceptance among physicians and patients, this formulation strengthens an anti-diabetic product portfolio and supports consistent demand in diabetes management.
Common side effects may include mild gastrointestinal discomfort, nausea, bloating, diarrhea, or flatulence. Rarely, lactic acidosis or hypoglycemia may occur, especially in patients with renal or hepatic impairment.
Vogliviga M 0.3 Forte Tablet is indicated for the management of type 2 diabetes mellitus, either as monotherapy or in combination with diet, exercise, and other antidiabetic medications, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Take with meals to minimize gastrointestinal side effects. Regular monitoring of blood glucose and renal function is recommended during prolonged therapy.
Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination has strong demand in the diabetology and endocrinology segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on chronic diabetes care portfolios.
Medical distributors and agencies can benefit from consistent, long-term demand for Type 2 diabetes management under medical supervision. Metformin 1000mg is a first-line oral anti-diabetic that improves insulin sensitivity Voglibose 0.3mg helps control post-meal blood sugar spikes by delaying carbohydrate absorption Commonly prescribed for Type 2 diabetes mellitus, especially in patients with uncontrolled postprandial glucose levels Fixed-dose combination improves patient compliance and treatment effectiveness This strengthens a strong and stable chronic disease portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metformin + Voglibose Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high prescription demand in diabetes care, long-term repeat sales, steady year-round consumption, reliable supply chain support, and attractive margins in the anti-diabetic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality products, and a dependable supply chain to grow their pharmaceutical business successfully.